Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 13 Weeks

27-May-17 - 25-Aug-17
Buy Ratio:35%

Down

# Net Buyers:58
# Net Sellers:108

Previous 13 Weeks

25-Feb-17 - 26-May-17
Buy Ratio:37%
# Net Buyers:81
# Net Sellers:139
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Mylan N.V.($1.59M)$1.83B  
Valeant Pharmaceuticals International, Inc.($14.63M)$151.51M  
Regeneron Pharmaceuticals Inc$58.87M$64.88M  
Global Blood Therapeutics, Inc.($3.88M)$49.40M  
Esperion Therapeutics, Inc.--$49.31M  
New Net Buyers
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals Inc$58.87M$64.88M  
Eagle Pharmaceuticals, Inc.$19.41K$30.13M  
Bristol Myers Squibb Co$291.70K$27.52M  
Alnylam Pharmaceuticals, Inc.$22.10M$26.43M  
Amicus Therapeutics Inc$18.68M$19.55M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.--($716.39M)  
Juno Therapeutics, Inc.($217.71M)($218.27M)  
Vertex Pharmaceuticals Inc / Ma($120.20M)($84.12M)  
Nexvet Biopharma Plc($76.62M)($76.62M)  
Celgene Corp /de/($37.12M)($31.38M)  
New Net Sellers
CompanyNet Buy AmountChange
Juno Therapeutics, Inc.($217.71M)($218.27M)  
Agios Pharmaceuticals Inc($4.26M)($19.67M)  
Biogen Inc.($1.91M)($13.19M)  
Cara Therapeutics, Inc.($466.25K)($9.56M)  
Calithera Biosciences, Inc.($104.21K)($5.08M)